Surgery Partners Income Statement (2013-2026) | SGRY

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	543.30M	559.20M	610.20M	596.20M	615.40M	620.60M	707.10M	666.20M	667.60M	674.10M	735.40M	717.40M	762.10M	770.40M	864.40M	776.00M	826.20M	821.50M	885.00M	810.90M
Cost of Revenue (Quarter)	157.50M	34.10M	33.90M	37.30M	38.50M	41.00M	592.90M	45.60M	41.40M	40.60M	-374.50M	54.10M	45.40M	48.20M	223.00M	43.60M	55.40M	49.00M	53.40M	220.20M
Gross Profit (Quarter)	385.80M	525.10M	576.30M	558.90M	576.90M	579.60M	114.20M	620.60M	626.20M	633.50M	1,109.90M	663.30M	716.70M	722.20M	641.40M	732.40M	770.80M	772.50M	831.60M	590.70M
Operating items
Depreciation & Amortization - Total (Quarter)
Selling, General & Administrative (Quarter)	24.50M	25.50M	27.20M	29.50M	26.10M	17.90M	28.70M	32.00M	31.20M	36.80M	20.90M	33.20M	40.30M	29.20M	36.00M	36.00M	36.10M	22.40M	23.70M	39.30M
Restructuring Costs (Quarter)	9.20M	10.20M	15.10M	7.10M	8.20M	12.50M	19.70M	12.50M	12.00M	12.80M	24.40M	17.40M	19.30M	29.40M	34.00M	24.70M	18.10M	12.60M	18.50M	15.60M
Other Operating Expenses (Quarter)				32.80M			-3.50M	-3.00M	-1.50M	-3.60M	-2.50M	1.80M	-0.50M	-0.50M		-2.20M		-5.10M		-2.50M
Operating Expenses (Quarter)	483.80M	436.70M	463.10M	471.40M	480.80M	489.40M	522.80M	532.20M	570.00M	508.30M	314.50M	562.10M	677.30M	592.90M	737.30M	714.10M	630.60M	715.80M	399.30M	650.70M
Operating Income (Quarter)	59.50M	63.60M	114.80M	100.40M	76.50M	74.10M	94.20M	46.40M	97.60M	82.60M	101.40M	76.00M	84.80M	60.90M	127.10M	61.90M	111.70M	105.70M	110.20M	65.80M
EBIT (Quarter)	59.50M	63.60M	114.80M	100.40M	76.50M	74.10M	94.20M	46.40M	97.60M	82.60M	101.40M	76.00M	84.80M	60.90M	127.10M	61.90M	111.70M	105.70M	110.20M	65.80M
Non-operating items
Interest & Investment Income (Quarter)	-53.40M	-54.20M	-60.10M	-56.30M	-56.90M	-60.70M	-61.00M	-46.80M	-47.70M	-49.80M	-48.70M	-47.30M	-51.50M	-50.00M	-52.90M	-62.20M	-67.90M	-74.90M	-67.60M	-69.10M
Other Non Operating Income (Quarter)	-9.60M	0.50M					-13.90M				-15.50M		-5.10M					-1.30M
Net income details
EBT (Quarter)	6.10M	9.40M	54.70M	44.10M	19.60M	13.40M	33.20M	-0.40M	49.90M	32.80M	52.70M	28.70M	33.30M	10.90M	74.20M	-0.30M	43.80M	30.80M	42.60M	-3.30M
Tax Provisions (Quarter)	-2.70M	1.20M	11.80M	1.30M	4.30M	7.80M	9.90M	-1.60M	-7.80M	3.10M	6.00M	4.40M	4.90M	4.50M	120.80M		-1.10M	5.50M	13.60M	-1.20M
Profit After Tax (Quarter)	-26.90M	8.20M	-98.70M	12.20M	-18.40M	-25.00M	118.20M	1.20M	57.70M	29.70M	-100.50M	-12.40M	28.40M	-31.70M	-108.50M	-0.30M	44.90M	25.30M	-15.00M	-2.10M
Equity Income (Quarter)	3.00M	2.90M	2.80M	3.10M	2.60M	2.40M	4.40M	3.30M	2.60M	3.50M	4.80M	2.70M	4.40M	5.20M	7.20M	5.60M	5.50M	5.20M	6.60M	4.10M
Income from Non-Controlling Interests (Quarter)	35.70M	31.10M	43.00M	30.60M	33.70M	30.60M	46.70M	26.10M	38.80M	34.60M	47.70M	36.70M	43.90M	38.10M	61.90M	37.40M	47.40M	48.00M	44.00M	33.80M
Income from Continuing Operations (Quarter)	8.80M	8.20M	42.90M	42.80M	15.30M	5.60M	23.30M	1.20M	57.70M	29.70M	46.70M	24.30M	28.40M	6.40M	-46.60M	-0.30M	44.90M	25.30M	29.00M	-2.10M
Consolidated Net Income (Quarter)	8.80M	8.20M	42.90M	42.80M	15.30M	5.60M	23.30M	1.20M	57.70M	29.70M	46.70M	24.30M	28.40M	6.40M	-46.60M	-0.30M	44.90M	25.30M	29.00M	-2.10M
Income towards Parent Company (Quarter)	8.80M	8.20M	42.90M	42.80M	15.30M	5.60M	23.30M	1.20M	57.70M	29.70M	46.70M	24.30M	28.40M	6.40M	-46.60M	-0.30M	44.90M	25.30M	29.00M	-2.10M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-26.90M	-22.90M	-0.10M	12.20M	-18.40M	-25.00M	-23.40M	1.20M	57.70M	29.70M	46.70M	24.30M	28.40M	6.40M	-46.60M	-0.30M	44.90M	25.30M	29.00M	-2.10M
Additional items
EPS (Basic) (Quarter)	-0.39	-0.28	0.07	0.14	-0.21	-0.28	-0.24	-0.20	0.15	-0.04	0.37	-0.10	-0.12	-0.25	-0.86	-0.30	-0.02	-0.18	-0.11	-0.28
EPS (Weighted Average and Diluted) (Quarter)	-0.39	-0.28	0.07	0.14	-0.21	-0.28	-0.24	-0.20	0.15	-0.04	0.37	-0.10	-0.12	-0.25	-0.86	-0.30	-0.02	-0.18	-0.11	-0.28
Shares Outstanding (Weighted Average) (Quarter)	69.27M	68.35M	72.43M	88.00M	88.90M	88.60M	91.95M	125.21M	125.46M	125.56M	125.61M	125.97M	126.13M	126.09M	126.12M	126.60M	126.79M	127.21M	127.21M	128.37M
Shares Outstanding (Diluted Average) (Quarter)	69.27M	68.35M	72.43M	90.27M	88.45M	88.60M	91.95M	125.21M	125.46M	125.75M	125.61M	125.97M	126.13M	126.09M	126.12M	126.60M	126.98M	127.21M	127.21M	128.37M
EBITDA (Quarter)	59.50M	63.60M	114.80M	100.40M	76.50M	74.10M	94.20M	46.40M	97.60M	82.60M	101.40M	76.00M	84.80M	60.90M	127.10M	61.90M	111.70M	105.70M	110.20M	65.80M
Tax Rate (Quarter)	-44.26%	12.77%	21.57%	2.95%	21.94%	58.21%	29.82%	400.00%	-15.63%	9.45%	11.39%	15.33%	14.71%	41.28%	162.80%		-2.51%	17.86%	31.92%	36.36%

Research Tools

Developers

Surgery Partners Income Statement (2013-2026) | SGRY

Research Tools

Developers

Surgery Partners Income Statement (2013-2026) | SGRY

Create an account

Sign In

Reset Password